文献速递妇科产科

自然绝经年龄与慢性病及多病共存发展的关联:澳大利亚前瞻性队列研究结果

Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort.
PubMed 文献 · Hum Reprod · 2020-01-01

在5107名报告自然绝经年龄的女性中,2.3%为早绝经(≤40岁),55.1%发生多病共存;与50-51岁绝经者相比,早绝经者60岁时多病共存 odds 约翻倍(OR=1.98,95%CI 1.31-2.98),60多岁期间约增至三倍(OR=3.03,95%CI 1.62-5.64)。

要点

  • 早绝经(≤40岁)与多病共存风险升高相关。
  • 60岁时多病共存OR=1.98,60多岁期间OR=3.03。
  • 早绝经者多数个体慢性病发病率也更高。

核心结论

  • 早绝经女性发生个体慢性病和多病共存的 odds 增加。

研究设计与样本

  • 分析样本为5107名报告自然绝经年龄的女性,每约3年评估11种慢性病。

主要发现

  • 5107名女性中2.3%为早绝经(≤40岁),55.1%发生多病共存。
  • 与50-51岁绝经者相比,早绝经者60岁时多病共存OR=1.98(95%CI 1.31-2.98)。
  • 早绝经者60多岁期间多病共存OR=3.03(95%CI 1.62-5.64)。
  • 早绝经者多数个体慢性病发病率更高。

关键数值与推荐

  • 多病共存定义为11种慢性病中发生2种及以上。
  • 11种慢性病包括糖尿病、高血压、心脏病、卒中、关节炎、骨质疏松、哮喘、慢性阻塞性肺疾病、抑郁、焦虑和乳腺癌。

临床怎么用

  • 治疗早绝经女性时应考虑全面筛查和评估多病共存危险因素。

局限性

  • 主要局限性为使用自我报告数据。
  • 前瞻性重复评估及多数慢性病医院数据验证可最小化非差异性错分可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is age at natural menopause (ANM) associated with the development of multiple chronic conditions (multimorbidity) in postmenopausal life? SUMMARY ANSWER: Women with premature menopause experience increased odds of developing individual chronic conditions and multimorbidity. WHAT IS KNOWN ALREADY: ANM is considered as a marker of age-related morbidity and mortality in postmenopausal life. Multimorbidity affects more than 60% of older women and has been recognized as the most common 'chronic condition'. Few studies have examined the association between ANM and the development of multimorbidity. STUDY DESIGN, SIZE, DURATION: A prospective national cohort study of 11 258 Australian women, aged 45-50 years in 1996. Women were followed from 1996 to 2016. PARTICIPANTS/MATERIALS, SETTING, METHODS: Information about ANM and 11 chronic conditions (diabetes, hypertension, heart disease, stroke, arthritis, osteoporosis, asthma, chronic obstructive pulmonary disease, depression, anxiety and breast cancer) were estimated approximately every 3 years. Multimorbidity is defined as 2 or more of these 11 conditions. Generalized estimating equations were used to link the categorical ANM with individual chronic conditions and multimorbidity. MAIN RESULTS AND THE ROLE OF CHANCE: Among 5107 women reporting ANM, 2.3% experienced premature menopause (≤40 years) and 55.1% developed multimorbidity. Compared with women who experienced menopause at age 50-51 years, women with premature menopause had twice the odds of experiencing multimorbidity by age 60 (OR = 1.98, 95% CI 1.31 to 2.98) and three times the odds of developing multimorbidity in their 60s (OR = 3.03, 95% CI 1.62 to 5.64). Women with premature menopause also experienced higher incidence of most individual chronic conditions. LIMITATIONS, REASONS FOR CAUTION: The main limitation of this study was the use of self-reported data, but with repeated assessments from prospective study design and the validity of most of the chronic conditions from hospital data, the potential for non-differential misclassification is minimized. WIDE IMPLICATIONS OF THE FINDINGS: To our knowledge, this is the first study to assess the association of premature menopause and development of multimorbidity in a larger national cohort of mid-aged women. Health professionals should consider comprehensive screening and assessment of risk factors for multimorbidity when treating women who experienced premature menopause. STUDY FUNDING/COMPETING INTEREST(S): The Australian Longitudinal Study on Women's Health was supported by the Australian Government Department of Health. X.X. is funded by an International Postgraduate Research Scholarship from the Australian government and a UQ Centennial Scholarship from The University of Queensland. G.D.M. is supported by the National Health and Medical Research Council Principal Research Fellowship (APP1121844). None of the authors has any conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Xu X, Jones M, Mishra GD, et al. Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort. Hum Reprod. 2020. PMID: 31955198. doi:10.1093/humrep/dez259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。